490 related articles for article (PubMed ID: 10925293)
1. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria.
Charest H; Sedegah M; Yap GS; Gazzinelli RT; Caspar P; Hoffman SL; Sher A
J Immunol; 2000 Aug; 165(4):2084-92. PubMed ID: 10925293
[TBL] [Abstract][Full Text] [Related]
2. Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.
Sedegah M; Brice GT; Rogers WO; Doolan DL; Charoenvit Y; Jones TR; Majam VF; Belmonte A; Lu M; Belmonte M; Carucci DJ; Hoffman SL
Infect Immun; 2002 Jul; 70(7):3493-9. PubMed ID: 12065488
[TBL] [Abstract][Full Text] [Related]
3. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine.
Sedegah M; Jones TR; Kaur M; Hedstrom R; Hobart P; Tine JA; Hoffman SL
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7648-53. PubMed ID: 9636204
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus.
Oliveira-Ferreira J; Miyahira Y; Layton GT; Savage N; Esteban M; Rodriguez D; Rodriguez JR; Nussenzweig RS; Zavala F
Vaccine; 2000 Mar; 18(17):1863-9. PubMed ID: 10699335
[TBL] [Abstract][Full Text] [Related]
5. Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus.
Sedegah M; Weiss W; Sacci JB; Charoenvit Y; Hedstrom R; Gowda K; Majam VF; Tine J; Kumar S; Hobart P; Hoffman SL
J Immunol; 2000 Jun; 164(11):5905-12. PubMed ID: 10820272
[TBL] [Abstract][Full Text] [Related]
6. Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium yoelii.
González-Aseguinolaza G; Nakaya Y; Molano A; Dy E; Esteban M; Rodríguez D; Rodríguez JR; Palese P; García-Sastre A; Nussenzweig RS
J Virol; 2003 Nov; 77(21):11859-66. PubMed ID: 14557672
[TBL] [Abstract][Full Text] [Related]
7. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.
Li S; Rodrigues M; Rodriguez D; Rodriguez JR; Esteban M; Palese P; Nussenzweig RS; Zavala F
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5214-8. PubMed ID: 7685119
[TBL] [Abstract][Full Text] [Related]
8. Cellular immune response to DNA and vaccinia prime-boost immunization kills Plasmodium yoelii-infected hepatocytes in vitro.
Sacci JB; Hollingdale MR; Sedegah M
Pathog Dis; 2017 Jun; 75(4):. PubMed ID: 28475711
[TBL] [Abstract][Full Text] [Related]
9. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
[TBL] [Abstract][Full Text] [Related]
10. Partial protection against malaria by immunization with Leishmania enriettii expressing the Plasmodium yoelii circumsporozoite protein.
Wang HH; Rogers WO; Kang YH; Sedegah M; Hoffman SL
Mol Biochem Parasitol; 1995 Feb; 69(2):139-48. PubMed ID: 7770079
[TBL] [Abstract][Full Text] [Related]
11. Antibody-Dependent, Gamma Interferon-Independent Sterilizing Immunity Induced by a Subunit Malaria Vaccine.
Chawla B; Mahajan B; Oakley M; Majam VF; Belmonte A; Sedegah M; Shimp RL; Kaslow DC; Kumar S
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31308085
[TBL] [Abstract][Full Text] [Related]
12. Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine.
Wang R; Charoenvit Y; Daly TM; Long CA; Corradin G; Hoffman SL
Immunol Lett; 1996 Nov; 53(2-3):83-93. PubMed ID: 9024983
[TBL] [Abstract][Full Text] [Related]
13. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.
Rodrigues M; Li S; Murata K; Rodriguez D; Rodriguez JR; Bacik I; Bennink JR; Yewdell JW; Garcia-Sastre A; Nussenzweig RS
J Immunol; 1994 Nov; 153(10):4636-48. PubMed ID: 7525709
[TBL] [Abstract][Full Text] [Related]
14. Vaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of Plasmodium.
Rodríguez D; González-Aseguinolaza G; Rodríguez JR; Vijayan A; Gherardi M; Rueda P; Casal JI; Esteban M
PLoS One; 2012; 7(4):e34445. PubMed ID: 22529915
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice.
Caetano BC; Bruña-Romero O; Fux B; Mendes EA; Penido ML; Gazzinelli RT
Hum Gene Ther; 2006 Apr; 17(4):415-26. PubMed ID: 16610929
[TBL] [Abstract][Full Text] [Related]
16. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
[TBL] [Abstract][Full Text] [Related]
17. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
18. Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria.
Lanar DE; Tine JA; de Taisne C; Seguin MC; Cox WI; Winslow JP; Ware LA; Kauffman EB; Gordon D; Ballou WR; Paoletti E; Sadoff JC
Infect Immun; 1996 May; 64(5):1666-71. PubMed ID: 8613376
[TBL] [Abstract][Full Text] [Related]
19. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii.
Khan IA; Casciotti L
J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393
[TBL] [Abstract][Full Text] [Related]
20. Immunological responses of neonates and infants to DNA vaccines.
Sedegah M; Hoffman SL
Methods Mol Med; 2006; 127():239-51. PubMed ID: 16988458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
